Alvotech (ALVO) Current Assets (2021 - 2026)
Alvotech (ALVO) posted Current Assets of $456.0 million for Q1 2026, down 20.56% on a QoQ basis from $574.0 million in Q4 2025, and down 0.63% year-over-year from $458.9 million in Q1 2025.
Alvotech (ALVO) Current Assets (2021 - 2026) Analysis & Trends
Alvotech's Current Assets history runs 6 years deep, the most recent figure standing at $456.0 million for Q1 2026.
- Quarterly Current Assets fell 0.63% year-over-year to $456.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $456.0 million (down 0.63% YoY) and the FY2025 annual result came in at $574.0 million, up 26.15% from the prior year.
- Current Assets was $456.0 million for Q1 2026 at Alvotech, down from $574.0 million in the prior quarter.
- Across five years, Current Assets topped out at $574.0 million in Q4 2025 and bottomed at $194.8 million in Q4 2023.
- A 5-year average of $361.7 million and a median of $362.5 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2023 — Current Assets slipped 15.56% — and 2024, when it jumped 133.53%.
- Alvotech's Current Assets stood at $230.7 million in 2022, then declined by 15.56% to $194.8 million in 2023, then soared by 133.53% to $455.0 million in 2024, then grew by 26.15% to $574.0 million in 2025, then slipped by 20.56% to $456.0 million in 2026.
- Business Quant data shows ALVO's Current Assets at $456.0 million in Q1 2026, $574.0 million in Q4 2025, and $455.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Alvotech | 935.87 Mn | 935.87 Mn | 5.09 Mn | 455.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 455.98 Mn |
| Dec 31, 2025 | 574.02 Mn |
| Sep 30, 2025 | 455.02 Mn |
| Jun 30, 2025 | 509.46 Mn |
| Mar 31, 2025 | 458.87 Mn |
| Dec 31, 2024 | 455.02 Mn |
| Sep 30, 2024 | 432.61 Mn |
| Jun 30, 2024 | 285.19 Mn |
| Mar 31, 2024 | 292.30 Mn |
| Dec 31, 2023 | 194.84 Mn |
| Jun 30, 2023 | 211.91 Mn |
| Mar 31, 2023 | 269.14 Mn |
| Dec 31, 2022 | 230.74 Mn |
| Jun 30, 2022 | 238.66 Mn |
| Dec 31, 2021 | 119.82 Mn |